Physician profile
Amanda M Woodward
NPI 1013464114
$650.56
in general payments reported to CMS, 2019-2025
20 companies · $143 in 2025
The $143 reported for 2025 was more than what a typical Hospice and Palliative Medicine (Family Medicine) provider received nationally (typical 2025 total: $78.57).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.31 · 2023: $153 · 2024: $331 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $239.19 | 2024 | |
| Janssen Biotech, INC. | $47.46 | 2022-2025 | Rybrevant |
| Novartis Pharmaceuticals Corporation | $36.74 | 2023-2025 | |
| Eisai INC. | $32.73 | 2023-2024 | |
| Iovance Biotherapeutics, INC. | $25.39 | 2025 | Amtagvi |
| Emd Serono, INC. | $21.16 | 2024 | |
| Sobi, INC | $21.00 | 2024 | |
| Merck Sharp & Dohme LLC | $20.81 | 2025 | Keytruda |
| Astrazeneca Pharmaceuticals Lp | $20.50 | 2023 | Tagrisso |
| Vertex Pharmaceuticals Incorporated | $20.46 | 2025 | |
| Seagen INC. | $20.26 | 2023 | Tivdak |
| Incyte Corporation | $20.08 | 2023 | Jakafi |
| Beone Medicines USA, INC. | $17.28 | 2025 | Brukinsa |
| Caris Mpi, INC. | $17.13 | 2025 | Mi Cancer Seek |
| Apellis Pharmaceuticals, INC. | $17.10 | 2024 | Empaveli |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| G1 Therapeutics, INC. | $15.57 | 2023 | Cosela |
| Genzyme Corporation | $15.37 | 2024 | |
| Genentech USA, INC. | $14.82 | 2023 | Perjeta, Columvi, Phesgo |
| Adaptive Biotechnologies Corporation | $13.96 | 2023 | Clonoseq |
| Agios Pharmaceuticals, INC. | $13.55 | 2023 | Pyrukynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Woodward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.